The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation

Autoimmunity Reviews

Volumn 15, Issue 7, 2016, Pages 684-689

  Wu, Haijing ^a   Zhao, Ming ^a   Tan, Lina ^a   Lu, Qianjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

DNA methylation; Epigenetics; SLE; T cells

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER;

ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; B LYMPHOCYTE; DNA METHYLATION; EPIGENETICS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TISSUE INJURY; GENETICS; PATHOLOGY; PROCEDURES;

DNA METHYLATION; EPIGENOMICS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 84962553077     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.03.002     Document Type: Review

References (112)

1. D'Cruz D.P., Khamashta M.A., Hughes G.R. Systemic lupus erythematosus. Lancet 2007, 369:587-596.
2. Tsokos G.C. Systemic lupus erythematosus. N Engl J Med 2011, 365:2110-2121.
3. Danchenko N., Satia J.A., Anthony M.S. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006, 15:308-318.
4. O'Neill S., Cervera R. Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2010, 24:841-855.
5. Takeno M., Nagafuchi H., Kaneko S., Wakisaka S., Oneda K., Takeba Y., et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J Immunol 1997, 158:3529-3538.
6. Santulli-Marotto S., Retter M.W., Gee R., Mamula M.J., Clarke S.H. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 1998, 8:209-219.
7. Tan E.M., Kunkel H.G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966, 96:464-471.
8. Yu C., Gershwin M.E., Chang C. Diagnostic criteria for systemic lupus erythematosus: a critical review. J Autoimmun 2014, (48-49:10-3).
9. Gatto M., Zen M., Ghirardello A., Bettio S., Bassi N., Iaccarino L., et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013, 12:523-536.
10. Joseph F.G., Lammie G.A., Scolding N.J. CNS lupus: a study of 41 patients. Neurology 2007, 69:644-654.
11. Kuhn A., Ruland V., Bonsmann G. Cutaneous lupus erythematosus: update of therapeutic options part II. J Am Acad Dermatol 2011, 65:e195-e213.
12. Gabba A., Piga M., Vacca A., Porru G., Garau P., Cauli A., et al. Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients. Rheumatology (Oxford) 2012, 51:2278-2285.
13. Wanitpongpun C., Teawtrakul N., Mahakkanukrauh A., Siritunyaporn S., Sirijerachai C., Chansung K. Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. Clin Exp Rheumatol 2012, 30:825-829.
14. Jeffries M.A., Sawalha A.H. Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumatol 2011, 6:423-439.
15. Rhodes B., Vyse T.J. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 2008, 47:1603-1611.
16. Quddus J., Johnson K.J., Gavalchin J., Amento E.P., Chrisp C.E., Yung R.L., et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53.
17. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
18. Straussman R., Nejman D., Roberts D., Steinfeld I., Blum B., Benvenisty N., et al. Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol 2009, 16:564-571.
19. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16. (Spec No 1:R50-9).
20. Lopez-Serra L., Esteller M. Proteins that bind methylated DNA and human cancer: reading the wrong words. Br J Cancer 2008, 98:1881-1885.
21. Kuroda A., Rauch T.A., Todorov I., Ku H.T., Al-Abdullah I.H., Kandeel F., et al. Insulin gene expression is regulated by DNA methylation. PLoS One 2009, 4.
22. Doi A., Park I.H., Wen B., Murakami P., Aryee M.J., Irizarry R., et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009, 41:1350-1353.
23. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
24. Denis H., Ndlovu M.N., Fuks F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep 2011, 12:647-656.
25. Cannat A., Seligmann M. Induction by isoniazid and hydrallazine of antinuclear factors in mice. Clin Exp Immunol 1968, 3:99-105.
26. Mizugaki M., Yamaguchi T., Ishiwata S., Shindo H., Hishinuma T., Nozaki S., et al. Alteration of DNA methylation levels in MRL lupus mice. Clin Exp Immunol 1997, 110:265-269.
27. Zhou Y., Lu Q. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients. Autoimmun Rev 2008, 7:376-383.
28. Javierre B.M., Fernandez A.F., Richter J., Al-Shahrour F., Martin-Subero J.I., Rodriguez-Ubreva J., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010, 20:170-179.
29. Zhao M., Liu S., Luo S., Wu H., Tang M., Cheng W., et al. DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun 2014, 54:127-136.
30. Richardson B., Scheinbart L., Strahler J., Gross L., Hanash S., Johnson M. Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33:1665-1673.
31. Takeuchi T., Amano K., Sekine H., Koide J., Abe T. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest 1993, 92:3008-3016.
32. Coit P., Jeffries M., Altorok N., Dozmorov M.G., Koelsch K.A., Wren J.D., et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 2013, 43:78-84.
33. Renauer P., Coit P., Jeffries M.A., Merrill J.T., McCune W.J., Maksimowicz-McKinnon K., et al. DNA methylation patterns in naive CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci Med 2015, 2.
34. Coit P., Renauer P., Jeffries M.A., Merrill J.T., McCune W.J., Maksimowicz-McKinnon K., et al. Renal involvement in lupus is characterized by unique DNA methylation changes in naive CD4+ T cells. J Autoimmun 2015, 61:29-35.
35. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 2010, 11:674-680.
36. Palmer M.T., Weaver C.T. Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat Immunol 2010, 11:36-40.
37. Chan R.W., Lai F.M., Li E.K., Tam L.S., Chow K.M., Li P.K., et al. Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis. Rheumatology (Oxford) 2006, 45:951-957.
38. Yang J., Chu Y., Yang X., Gao D., Zhu L., Yang X., et al. Th17 and natural treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 2009, 60:1472-1483.
39. Feng X., Wang D., Chen J., Lu L., Hua B., Li X., et al. Inhibition of aberrant circulating Tfh cell proportions by corticosteroids in patients with systemic lupus erythematosus. PLoS One 2012, 7.
40. Choi J.Y., Hsi-enHo J., Pasoto S.G., Bunin V., Kim S., Carrasco S., et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheum 2015.
41. Cornacchia E., Golbus J., Maybaum J., Strahler J., Hanash S., Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988, 140:2197-2200.
42. Ballas Z.K. The use of 5-azacytidine to establish constitutive interleukin 2-producing clones of the EL4 thymoma. J Immunol 1984, 133:7-9.
43. Agarwal S., Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 1998, 9:765-775.
44. Bix M., Locksley R.M. Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. Science 1998, 281:1352-1354.
45. Lal G., Zhang N., van der Touw W., Ding Y., Ju W., Bottinger E.P., et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 2009, 182:259-273.
46. Liu X., Lu H., Chen T., Nallaparaju K.C., Yan X., Tanaka S., et al. Genome-wide analysis identifies Bcl6-controlled regulatory networks during T Follicular helper cell differentiation. Cell Rep 2016.
47. Gorelik G.J., Yarlagadda S., Patel D.R., Richardson B.C. Protein kinase cdelta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum 2012, 64:2964-2974.
48. Khan F., Siddiqui A.A., Ali R. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol 2006, 64:507-514.
49. Oates J.C., Gilkeson G.S. The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. Clin Immunol 2006, 121:243-250.
50. Ross S.A., Poirier L. Proceedings of the trans-HHS workshop: diet, DNA methylation processes and health. J Nutr 2002, 132:2329S-2332S.
51. Somers E.C., Richardson B.C. Environmental exposures, epigenetic changes and the risk of lupus. Lupus 2014, 23:568-576.
52. Strickland F.M., Hewagama A., Wu A., Sawalha A.H., Delaney C., Hoeltzel M.F., et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum 2013, 65:1872-1881.
53. Xu J., Zhang G., Cheng Y., Chen B., Dong Y., Li L., et al. Hypomethylation of the HTR1A promoter region and high expression of HTR1A in the peripheral blood lymphocytes of patients with systemic lupus erythematosus. Lupus 2011, 20:678-689.
54. Lu Q., Kaplan M., Ray D., Ray D., Zacharek S., Gutsch D., et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002, 46:1282-1291.
55. Zhao M., Sun Y., Gao F., Wu X., Tang J., Yin H., et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 2010, 35:58-69.
56. Zhao M., Wu X., Zhang Q., Luo S., Liang G., Su Y., et al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther 2010, 12:R227.
57. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007, 3:521-527.
58. Renaudineau Y., Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med 2011, 60:10-16.
59. Nagafuchi H., Shimoyama Y., Kashiwakura J., Takeno M., Sakane T., Suzuki N. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2003, 21:71-77.
60. Li Y., Zhao M., Yin H., Gao F., Wu X., Luo Y., et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum 2010, 62:1438-1447.
61. Li Y., Huang C., Zhao M., Liang G., Xiao R., Yung S., et al. A possible role of HMGB1 in DNA demethylation in CD4+ T cells from patients with systemic lupus erythematosus. Clin Dev Immunol 2013, 2013:206298.
62. Zhao M., Zhou Y., Zhu B., Wan M., Jiang T., Tan Q., et al. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis 2016.
63. Liu Y., Chen Y., Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells. Clin Immunol 2009, 132:257-265.
64. Zhao M., Tang J., Gao F., Wu X., Liang Y., Yin H., et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J Biomed Biotechnol 2010, 2010:931018.
65. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010, 184:6773-6781.
66. Pastor W.A., Aravind L., Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013, 14:341-356.
67. Deng C., Lu Q., Zhang Z., Rao T., Attwood J., Yung R., et al. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 2003, 48:746-756.
68. Gorelik G., Fang J.Y., Wu A., Sawalha A.H., Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007, 179:5553-5563.
69. Gorelik G., Sawalha A.H., Patel D., Johnson K., Richardson B. T cell PKCdelta kinase inactivation induces lupus-like autoimmunity in mice. Clin Immunol 2015, 158:193-203.
70. Miyamoto A., Nakayama K., Imaki H., Hirose S., Jiang Y., Abe M., et al. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature 2002, 416:865-869.
71. Mecklenbrauker I., Saijo K., Zheng N.Y., Leitges M., Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 2002, 416:860-865.
72. Sawalha A.H., Jeffries M., Webb R., Lu Q., Gorelik G., Ray D., et al. Defective T-cell ERK signaling induces interferon-regulated gene expression and overexpression of methylation-sensitive genes similar to lupus patients. Genes Immun 2008, 9:368-378.
73. Truong T.P., Sakata-Yanagimoto M., Yamada M., Nagae G., Enami T., Nakamoto-Matsubara R., et al. Age-dependent decrease of DNA hydroxymethylation in human T cells. J Clin Exp Hematop 2015, 55:1-6.
74. Cheng Y., Xie N., Jin P., Wang T. DNA methylation and hydroxymethylation in stem cells. Cell Biochem Funct 2015, 33:161-173.
75. Tan L., Xiong L., Xu W., Wu F., Huang N., Xu Y., et al. Genome-wide comparison of DNA hydroxymethylation in mouse embryonic stem cells and neural progenitor cells by a new comparative hMeDIP-seq method. Nucleic Acids Res 2013, 41.
76. Ichiyama K., Chen T., Wang X., Yan X., Kim B.S., Tanaka S., et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 2015, 42:613-626.
77. Danbara M., Kameyama K., Higashihara M., Takagaki Y. DNA methylation dominates transcriptional silencing of Pax5 in terminally differentiated B cell lines. Mol Immunol 2002, 38:1161-1166.
78. Amaravadi L., Klemsz M.J. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol 1999, 18:875-884.
79. Walter K., Bonifer C., Tagoh H. Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 2008, 112:1673-1682.
80. Garaud S., Le Dantec C., Jousse-Joulin S., Hanrotel-Saliou C., Saraux A., Mageed R.A., et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J Immunol 2009, 182:5623-5632.
81. Fali T., Le Dantec C., Thabet Y., Jousse S., Hanrotel C., Youinou P., et al. DNA methylation modulates HRES1/p28 expression in B cells from patients with lupus. Autoimmunity 2014, 47:265-271.
82. Mazari L., Ouarzane M., Zouali M. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A 2007, 104:6317-6322.
83. Fraenkel S., Mostoslavsky R., Novobrantseva T.I., Pelanda R., Chaudhuri J., Esposito G., et al. Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus. Nat Immunol 2007, 8:715-722.
84. Giambra V., Volpi S., Emelyanov A.V., Pflugh D., Bothwell A.L., Norio P., et al. Pax5 and linker histone H1 coordinate DNA methylation and histone modifications in the 3' regulatory region of the immunoglobulin heavy chain locus. Mol Cell Biol 2008, 28:6123-6133.
85. Zhao S., Long H., Lu Q. Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol 2010, 39:3-9.
86. Chow J., Heard E. X inactivation and the complexities of silencing a sex chromosome. Curr Opin Cell Biol 2009, 21:359-366.
87. Biermann M.H., Veissi S., Maueroder C., Chaurio R., Berens C., Herrmann M., et al. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert Rev Clin Immunol 2014, 10:1151-1164.
88. Kis-Toth K., Tsokos G.C. Dendritic cell function in lupus: independent contributors or victims of aberrant immune regulation. Autoimmunity 2010, 43:121-130.
89. Chan V.S., Nie Y.J., Shen N., Yan S., Mok M.Y., Lau C.S. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun Rev 2012, 11:890-897.
90. Solomon D.H., Kavanaugh A.J., Schur P.H., American College of Rheumatology Ad Hoc Committee on Immunologic Testing G Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444.
91. Bizzaro N., Villalta D., Giavarina D., Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev 2012, 12:97-106.
92. Zieve G.W., Khusial P.R. The anti-Sm immune response in autoimmunity and cell biology. Autoimmun Rev 2003, 2:235-240.
93. Wang Y., Yu Y., Ye R., Zhang D., Li Q., An D., et al. An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese. Oncotarget 2016, 7:2754-2764.
94. Brennan K., Garcia-Closas M., Orr N., Fletcher O., Jones M., Ashworth A., et al. Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk. Cancer Res 2012, 72:2304-2313.
95. Amornpisutt R., Proungvitaya S., Jearanaikoon P., Limpaiboon T. DNA methylation level of OPCML and SFRP1: a potential diagnostic biomarker of cholangiocarcinoma. Tumour Biol 2015, 36:4973-4978.
96. Aparicio A., North B., Barske L., Wang X., Bollati V., Weisenberger D., et al. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics 2009, 4:176-184.
97. Szyf M. Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 2010, 39:62-77.
98. Campbell P.M., Bovenzi V., Szyf M. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis 2004, 25:499-507.
99. Detich N., Hamm S., Just G., Knox J.D., Szyf M. The methyl donor S-adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-adenosylmethionine. J Biol Chem 2003, 278:20812-20820.
100. Hosea Blewett H.J. Exploring the mechanisms behind S-adenosylmethionine (SAMe) in the treatment of osteoarthritis. Crit Rev Food Sci Nutr 2008, 48:458-463.
101. Zhang Z., Zhang R. Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmun Rev 2015, 14:854-863.
102. Annilo T., Kepp K., Laan M. Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. BMC Mol Biol 2009, 10:81.
103. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147.
104. Roadmap Epigenomics C., Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518:317-330.
105. Zouali M. Epigenetics in lupus. Ann N Y Acad Sci 2011, 1217:154-165.
106. Lei W., Luo Y., Lei W., Luo Y., Yan K., Zhao S., et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009, 38:369-374.
107. Wang G.S., Zhang M., Li X.P., Zhang H., Chen W., Kan M., et al. Ultraviolet B exposure of peripheral blood mononuclear cells of patients with systemic lupus erythematosus inhibits DNA methylation. Lupus 2009, 18:1037-1044.
108. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
109. Singer N.G., Richardson B.C., Powers D., Hooper F., Lialios F., Endres J., et al. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996, 88:537-543.
110. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
111. Sunahori K., Juang Y.T., Kyttaris V.C., Tsokos G.C. Promoter hypomethylation results in increased expression of protein phosphatase 2 A in T cells from patients with systemic lupus erythematosus. J Immunol 2011, 186:4508-4517.
112. Nakkuntod J., Avihingsanon Y., Mutirangura A., Hirankarn N. Hypomethylation of LINE-1 but not alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin Chim Acta 2011, 412:1457-1461.